Fiji vs Madagascar: Estimated antiretroviral therapy coverage among people living with HIV
Fiji
22.0%
in 2025
Madagascar
24.0%
in 2025
Fiji rank
141st
Madagascar rank
139th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Fiji
- Madagascar
How they compare
Madagascar currently reports 24.0% against 22.0% in Fiji, a difference of 2.0%.
That makes Madagascar's figure about 1.1 times Fiji's.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Madagascar ahead.
Fiji ranks 141st and Madagascar ranks 139th of 143 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 0.3% | 5.0% | Fiji |
| 2010s | 13.4% | 2.8% | 10.6% | Fiji |
| 2020s | 14.8% | 14.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Fiji or Madagascar?
- Madagascar, at 24.0% against 22.0% in Fiji as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Fiji and Madagascar?
- 2.0%, with Madagascar ahead.
- How many years of comparable data are there for Fiji and Madagascar?
- 26 years are reported by both, from 2000 to 2025.
- How do Fiji and Madagascar rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Fiji ranks 141st and Madagascar ranks 139th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.